Polymyalgia Rheumatica Market Report 2026
Download Free Sample Buy Now
Polymyalgia Rheumatica Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Polymyalgia Rheumatica Market Report 2026

Global Outlook – By Treatment (Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics), By Route Of Administration (Oral, Intravenous, Subcutaneous), By Patient Type (Adult, Geriatric, Elderly Or Aging Population), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Polymyalgia Rheumatica Market Overview

• Polymyalgia Rheumatica market size has reached to $1.36 billion in 2025

• Expected to grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%

• Growth Driver: Rising Demand For Personalized Medicine Driving Growth In The Market Due To Tailored Treatments And Advancements In Genetic Research

• Market Trend: FDA Approval Of Advanced IL-6 Receptor Blocker Offers New Treatment For Polymyalgia Rheumatica

• Asia-Pacific was the largest region in 2025.

What Is Covered Under Polymyalgia Rheumatica Market?

Polymyalgia rheumatica (PMR) is an inflammatory disorder that primarily affects older adults, causing muscle pain and stiffness, particularly in the shoulders, hips, and neck. It is characterized by aching and swelling in the muscles around the shoulders and hips, leading to difficulty in movement and daily activities.

The main treatment types of polymyalgia rheumatica are corticosteroids, nonsteroidal anti-inflammatory drugs, disease-modifying antirheumatic drugs, and biologics. Corticosteroids are the primary treatment for polymyalgia rheumatica (PMR), reducing inflammation and alleviating symptoms by mimicking adrenal hormones. It is administered through various routes of administration, such as oral, intravenous, and subcutaneous, for several patient types, such as adult, geriatric, and pediatric. It is distributed through various distribution channels, including hospital pharmacies, retail pharmacies, and online pharmacies.

Polymyalgia Rheumatica Market Global Report 2026 Market Report bar graph

What Is The Polymyalgia Rheumatica Market Size and Share 2026?

The polymyalgia rheumatica market size has grown strongly in recent years. It will grow from $1.36 billion in 2025 to $1.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to increasing aging population size, improved clinical awareness of inflammatory disorders, established use of corticosteroids as first-line therapy, growing diagnosis rates in geriatric patients, availability of hospital-based rheumatology services.

What Is The Polymyalgia Rheumatica Market Growth Forecast?

The polymyalgia rheumatica market size is expected to see strong growth in the next few years. It will grow to $1.81 billion in 2030 at a compound annual growth rate (CAGR) of 5.9%. The growth in the forecast period can be attributed to growing development of steroid-sparing therapies, rising research on inflammatory biomarkers, increasing adoption of biologics and targeted drugs, expanding access to specialized care, growing focus on reducing long-term treatment side effects. Major trends in the forecast period include increasing adoption of biologic therapies, rising focus on early and accurate diagnosis, growing use of long-term corticosteroid management, expansion of personalized treatment approaches, enhanced monitoring of disease progression.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Polymyalgia Rheumatica Market Segmentation

1) By Treatment: Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics

2) By Route Of Administration: Oral, Intravenous, Subcutaneous

3) By Patient Type: Adult, Geriatric, Elderly Or Aging Population

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Corticosteroids: Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone

2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Aspirin, Celecoxib

3) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine

4) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-6 (IL-6) Inhibitors, B-Cell Inhibitors, Janus Kinase (JAK) Inhibitors

What Are The Drivers Of The Polymyalgia Rheumatica Market?

The rise in demand for personalized medicine is expected to propel the growth of the polymyalgia rheumatica market going forward. Personalized medicine is medical treatment tailored to an individual’s genetic profile, lifestyle, and specific health conditions for more effective outcomes. The demand for personalized medicine is driven by advancements in genetic research, growing patient expectations for tailored treatments, and improvements in diagnostic technologies. Genetic research provided a deeper understanding of individual genetic variations, allowing for more customized treatments targeting specific genetic markers. Personalized medicine can help select drugs that are most likely effective based on the patient’s characteristics, leading to a more effective and safer treatment plan. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the Food and Drug Administration approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the rise of personalized medicine is driving the growth of the polymyalgia rheumatica industry.

The growth in telemedicine services is expected to propel the growth of the polymyalgia rheumatica market going forward. Telemedicine services use digital communication technologies, such as video calls, phone calls, and online messaging, to provide remote medical consultations, diagnoses, treatment, and follow-up care to patients without the need for in-person visits. The growth in telemedicine services is due to increasing demand for convenient healthcare options and cost-effective healthcare solutions. Patients increasingly seek convenience, especially for non-urgent consultations, which telemedicine offers by eliminating the need for in-person visits. The growth of telemedicine services supports polymyalgia rheumatica (PMR) by enabling remote monitoring of symptoms, medication management, and regular follow-ups, which are crucial for managing chronic pain and inflammation. For instance, in November 2024, according to the Australian Bureau of Statistics, an Australia-based government agency, in 2022-23, people using telehealth consultation was 87.7%, which reached 89.2% in 2023-24. Therefore, the growth in telemedicine services is driving the growth of the polymyalgia rheumatica industry.

Key Players In The Global Polymyalgia Rheumatica Market

Major companies operating in the polymyalgia rheumatica market are AbbVie Inc., Sanofi S.A., Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Horizon Therapeutics plc, Sparrow Pharmaceuticals Inc., Roche Holding AG, Novartis AG, Pfizer Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co. Inc., Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Amgen Inc., Boehringer Ingelheim, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Aurobindo Pharma Limited

Global Polymyalgia Rheumatica Market Trends and Insights

Major companies operating in the polymyalgia rheumatica market are focusing on developing advanced drugs, such as interleukin-6 (IL-6) receptor blockers, to provide more targeted and effective treatment options. Interleukin-6 (IL-6) receptor blockers are biological drugs that inhibit IL-6, a key pro-inflammatory cytokine in autoimmune diseases. By blocking IL-6, these treatments reduce inflammation and improve symptoms, enhancing the quality of life for PMR patients. For instance, in February 2023, Regeneron Pharmaceuticals, Inc., a US-based biotechnology company, and Sanofi, a France-based healthcare company, announced the Food and Drug Administration (FDA) approved Kevzara (sarilumab) for treating polymyalgia rheumatica (PMR) in adults who haven't responded well to corticosteroids or can't tolerate tapering off them. Kevzara, the first and only biologic approved for this condition, works by inhibiting IL-6-mediated signaling. The approval was based on a study where 28.3% of patients on sarilumab achieved sustained remission at week 52, compared to 10.3% on placebo2. Kevzara is administered via subcutaneous injection once every two weeks and is also approved for treating moderately to severely active rheumatoid arthritis. Sanofi's stock (SNY) is currently priced at $54.13 on the NASDAQ.

Need data on a specific region in this market?
Request Regional Data

Regional Outlook

Asia-Pacific was the largest region in the polymyalgia rheumatica market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Polymyalgia Rheumatica Market?

The polymyalgia rheumatica market consists of revenues earned by entities by providing services such as medication management, pain management, laboratory testing, and nutritional counseling. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymyalgia rheumatica market includes sales of disease-modifying anti-rheumatic drugs, calcium and vitamin D supplements, assistive devices, and physical therapy aids. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Polymyalgia Rheumatica Market Report 2026?

The polymyalgia rheumatica market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the polymyalgia rheumatica industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Polymyalgia Rheumatica Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.44 billion
Revenue Forecast In 2035 $1.81 billion
Growth Rate CAGR of 6.2% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment, Route Of Administration, Patient Type, Distribution Channel
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled AbbVie Inc., Sanofi S.A., Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Horizon Therapeutics plc, Sparrow Pharmaceuticals Inc., Roche Holding AG, Novartis AG, Pfizer Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co. Inc., Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Amgen Inc., Boehringer Ingelheim, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Aurobindo Pharma Limited
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Polymyalgia Rheumatica Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Polymyalgia Rheumatica Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Polymyalgia Rheumatica Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Polymyalgia Rheumatica Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Biologic Therapies

4.2.2 Rising Focus On Early And Accurate Diagnosis

4.2.3 Growing Use Of Long-Term Corticosteroid Management

4.2.4 Expansion Of Personalized Treatment Approaches

4.2.5 Enhanced Monitoring Of Disease Progression

5. Polymyalgia Rheumatica Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Clinics

5.3 Rheumatology Centers

5.4 Hospital Pharmacies

5.5 Retail Pharmacies

6. Polymyalgia Rheumatica Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Polymyalgia Rheumatica Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Polymyalgia Rheumatica PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Polymyalgia Rheumatica Market Size, Comparisons And Growth Rate Analysis

7.3. Global Polymyalgia Rheumatica Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Polymyalgia Rheumatica Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Polymyalgia Rheumatica Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Polymyalgia Rheumatica Market Segmentation

9.1. Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Nonsteroidal Anti-Inflammatory Drugs, Disease-Modifying Antirheumatic Drugs, Biologics

9.2. Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous

9.3. Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult, Geriatric, Elderly Or Aging Population

9.4. Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

9.5. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prednisone, Methylprednisolone, Hydrocortisone, Dexamethasone

9.6. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ibuprofen, Naproxen, Aspirin, Celecoxib

9.7. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Methotrexate, Leflunomide, Sulfasalazine, Hydroxychloroquine

9.8. Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tumor Necrosis Factor (TNF) Inhibitors, Interleukin-6 (IL-6) Inhibitors, B-Cell Inhibitors, Janus Kinase (JAK) Inhibitors

10. Polymyalgia Rheumatica Market Regional And Country Analysis

10.1. Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Polymyalgia Rheumatica Market

11.1. Asia-Pacific Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Polymyalgia Rheumatica Market

12.1. China Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Polymyalgia Rheumatica Market

13.1. India Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Polymyalgia Rheumatica Market

14.1. Japan Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Polymyalgia Rheumatica Market

15.1. Australia Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Polymyalgia Rheumatica Market

16.1. Indonesia Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Polymyalgia Rheumatica Market

17.1. South Korea Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Polymyalgia Rheumatica Market

18.1. Taiwan Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Polymyalgia Rheumatica Market

19.1. South East Asia Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Polymyalgia Rheumatica Market

20.1. Western Europe Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Polymyalgia Rheumatica Market

21.1. UK Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Polymyalgia Rheumatica Market

22.1. Germany Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Polymyalgia Rheumatica Market

23.1. France Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Polymyalgia Rheumatica Market

24.1. Italy Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Polymyalgia Rheumatica Market

25.1. Spain Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Polymyalgia Rheumatica Market

26.1. Eastern Europe Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Polymyalgia Rheumatica Market

27.1. Russia Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Polymyalgia Rheumatica Market

28.1. North America Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Polymyalgia Rheumatica Market

29.1. USA Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Polymyalgia Rheumatica Market

30.1. Canada Polymyalgia Rheumatica Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Polymyalgia Rheumatica Market

31.1. South America Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Polymyalgia Rheumatica Market

32.1. Brazil Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Polymyalgia Rheumatica Market

33.1. Middle East Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Polymyalgia Rheumatica Market

34.1. Africa Polymyalgia Rheumatica Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Polymyalgia Rheumatica Market, Segmentation By Treatment, Segmentation By Route Of Administration, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Polymyalgia Rheumatica Market Regulatory and Investment Landscape

36. Polymyalgia Rheumatica Market Competitive Landscape And Company Profiles

36.1. Polymyalgia Rheumatica Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Polymyalgia Rheumatica Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Polymyalgia Rheumatica Market Company Profiles

36.3.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Eli Lilly and Co. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Regeneron Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Horizon Therapeutics plc Overview, Products and Services, Strategy and Financial Analysis

37. Polymyalgia Rheumatica Market Other Major And Innovative Companies

Sparrow Pharmaceuticals Inc., Roche Holding AG, Novartis AG, Pfizer Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co. Inc., Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Amgen Inc., Boehringer Ingelheim, Bayer AG, Teva Pharmaceutical Industries Ltd.

38. Global Polymyalgia Rheumatica Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Polymyalgia Rheumatica Market

40. Polymyalgia Rheumatica Market High Potential Countries, Segments and Strategies

40.1 Polymyalgia Rheumatica Market In 2030 - Countries Offering Most New Opportunities

40.2 Polymyalgia Rheumatica Market In 2030 - Segments Offering Most New Opportunities

40.3 Polymyalgia Rheumatica Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Polymyalgia Rheumatica Market, Overview Of Key Products - Product Examples
  • Table 2: Global Polymyalgia Rheumatica Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Polymyalgia Rheumatica Market, Supply Chain Analysis
  • Table 4: Global Polymyalgia Rheumatica Market, Major Raw Material Providers
  • Table 5: Global Polymyalgia Rheumatica Market, Major Resource Providers
  • Table 6: Global Polymyalgia Rheumatica Market, Major Manufacturers (Suppliers)
  • Table 7: Global Polymyalgia Rheumatica Market, Major Distributors And Channel Partners
  • Table 8: Global Polymyalgia Rheumatica Market, Key Technologies & Future Trends
  • Table 9: Global Polymyalgia Rheumatica Market, Major Trends
  • Table 10: Global Polymyalgia Rheumatica Market, Major End Users
  • Table 11: Global Polymyalgia Rheumatica Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Polymyalgia Rheumatica Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Polymyalgia Rheumatica Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Polymyalgia Rheumatica Market - TAM, US$ Billion, 2025
  • Table 15: Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: China, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: India, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Japan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Australia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: South Korea, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: UK, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: Germany, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: France, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Italy, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Spain, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Russia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: North America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: USA, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: Canada, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: South America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Brazil, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Middle East, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Africa, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Global Polymyalgia Rheumatica Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 98: Global Polymyalgia Rheumatica Market - Company Scoring Matrix
  • Table 99: AbbVie Inc. Financial Performance
  • Table 100: Sanofi S.A. Financial Performance
  • Table 101: Eli Lilly and Co. Financial Performance
  • Table 102: Regeneron Pharmaceuticals Inc. Financial Performance
  • Table 103: Horizon Therapeutics plc Financial Performance
  • Table 104: Global Polymyalgia Rheumatica Market, Competitive Benchmarking (In USD Billions)
  • Table 105: Global Polymyalgia Rheumatica Market, Competitive Dashboard
  • Table 106: Global Polymyalgia Rheumatica Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 107: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Table 108: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Table 109: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Patient Type, 2025 – 2030

List Of Figures

    Figure 1: Global Polymyalgia Rheumatica Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Polymyalgia Rheumatica Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Polymyalgia Rheumatica Market, Supply Chain Analysis
  • Figure 4: Global Polymyalgia Rheumatica Market, Major Raw Material Providers
  • Figure 5: Global Polymyalgia Rheumatica Market, Major Resource Providers
  • Figure 6: Global Polymyalgia Rheumatica Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Polymyalgia Rheumatica Market, Major Distributors And Channel Partners
  • Figure 8: Global Polymyalgia Rheumatica Market, Key Technologies & Future Trends
  • Figure 9: Global Polymyalgia Rheumatica Market, Major Trends
  • Figure 10: Global Polymyalgia Rheumatica Market, Major End Users
  • Figure 11: Global Polymyalgia Rheumatica Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Polymyalgia Rheumatica Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Polymyalgia Rheumatica Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Polymyalgia Rheumatica Market - TAM, US$ Billion, 2025
  • Figure 15: Global Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Polymyalgia Rheumatica Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Corticosteroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Disease-Modifying Antirheumatic Drugs (DMARDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Polymyalgia Rheumatica Market, Sub-Segmentation Of Biologics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Polymyalgia Rheumatica Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Polymyalgia Rheumatica Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: China, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: India, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Japan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Australia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: South Korea, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: UK, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: Germany, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: France, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Italy, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Spain, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Russia, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: North America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: USA, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: Canada, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: South America, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Brazil, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Middle East, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Polymyalgia Rheumatica Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Africa, Polymyalgia Rheumatica Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Polymyalgia Rheumatica Market, Segmentation By Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Global Polymyalgia Rheumatica Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 98: Global Polymyalgia Rheumatica Market - Company Scoring Matrix
  • Figure 99: AbbVie Inc. Financial Performance
  • Figure 100: Sanofi S.A. Financial Performance
  • Figure 101: Eli Lilly and Co. Financial Performance
  • Figure 102: Regeneron Pharmaceuticals Inc. Financial Performance
  • Figure 103: Horizon Therapeutics plc Financial Performance
  • Figure 104: Global Polymyalgia Rheumatica Market, Competitive Benchmarking (In USD Billions)
  • Figure 105: Global Polymyalgia Rheumatica Market, Competitive Dashboard
  • Figure 106: Global Polymyalgia Rheumatica Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 107: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030
  • Figure 108: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Route Of Administration, 2025 – 2030
  • Figure 109: Global, Polymyalgia Rheumatica Market Size Gain ($ Billion), Segmentation By Patient Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Gouty Arthritis Market Report 2026 - Global Outlook – By Type (Acute Gouty Arthritis, Chronic Gouty Arthritis), By Treatment (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Pain Reliever, Corticosteroids, Xanthine Oxida...

Fibromyalgia Treatment Market Report 2026 - Global Outlook – By Type (Symptomatic Treatment, Targeted Treatment), By Drug Class (Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs), By Distributio...

Esophageal Dysphagia Market Report 2026 - Global Outlook – By Treatment (Esophageal Dilation, Surgery, Stent Placement, Laparoscopic Heller Myotomy, Medications, Lifestyle Changes), By Diagnosis (Dynamic Swallowing Study...

Sciatica Market Report 2026 - Global Outlook – By Type (Acute Sciatica, Chronic Sciatica, Other Types), By Drugs (Oxycodone, Tramadol, Opioid Analgesics, Amitriptyline, Tricyclic Antidepressants, Other Drugs), By Treatme...

Osteoarthritis Market Report 2026 - Global Outlook – By Treatment (Medication, Surgery, Therapy), By Diagnosis (Imaging, Joint Fluid Analysis), By Route Of Administration (Parenteral Route, Topical Route, Oral Route), By...

Ankylosing Spondylitis Market Report 2026 - Global Outlook – By Treatment Type (Painkillers And Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biological Therapies, Stero...

Chronic Pain Market Report 2026 - Global Outlook – By Product (Drug, Devices ), By Indication (Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications), By End User (Ho...

Axial Spondyloarthritis (axSpA) Market Report 2026 - Global Outlook – By Type (Ankylosing Spondylitis (AS), Non-Radiographic Axial Spondyloarthritis (nr-axSpA)), By Commercialized Therapies (Anti-Tumor Necrosis Factor Th...

Frequently Asked Questions

The Polymyalgia Rheumatica market was valued at $1.36 billion in 2025, increased to $1.44 billion in 2026, and is projected to reach $1.81 billion by 2030.

The global Polymyalgia Rheumatica market is expected to grow at a CAGR of 5.9% from 2026 to 2035 to reach $1.81 billion by 2035.

Some Key Players in the Polymyalgia Rheumatica market Include, AbbVie Inc., Sanofi S.A., Eli Lilly and Co., Regeneron Pharmaceuticals Inc., Horizon Therapeutics plc, Sparrow Pharmaceuticals Inc., Roche Holding AG, Novartis AG, Pfizer Inc., Bristol Myers Squibb Company, GlaxoSmithKline plc, AstraZeneca plc, Merck & Co. Inc., Janssen Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, UCB S.A., Amgen Inc., Boehringer Ingelheim, Bayer AG, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Aurobindo Pharma Limited .

Major trend in this market includes: FDA Approval Of Advanced IL-6 Receptor Blocker Offers New Treatment For Polymyalgia Rheumatica. For further insights on this market. request a sample here

Asia-Pacific was the largest region in the polymyalgia rheumatica market in 2025. The regions covered in the polymyalgia rheumatica market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us